Loading…
for educational and safety purposes
Sermorelin and GHRP-6 both come up in the same conversations; they overlap on Growth Hormone. Sermorelin: Sermorelin is a synthetic analogue comprising the first 29 amino acids of growth hormone-releasing hormone (GHRH), the shortest fragment that retains full biological activity at the pituitary GHRH receptor. GHRP-6: GHRP-6 is one of the original growth hormone-releasing hexapeptides, a ghrelin-receptor agonist that prompts a pulse of the body's own growth hormone along with a marked increase in appetite.
Sermorelin is a synthetic analogue comprising the first 29 amino acids of growth hormone-releasing hormone (GHRH), the shortest fragment that retains full biological activity at the pituitary GHRH receptor. Rather than supplying growth hormone directly, it stimulates the somatotrophs to secrete the body's own hormone, preserving the natural pulsatile rhythm and leaving intact the negative feedback that guards against overexposure. Once approved for the diagnosis and treatment of growth hormone deficiency, it is now used chiefly in compounding and research settings, where interest centers on recovery, body composition, and sleep. The broader GHRH-receptor family it belongs to is under active study for effects well beyond the pituitary, including agonist protection in heart failure and antagonist activity against prostatic hyperplasia, fibrosis, and tumor growth.
GHRP-6 is one of the original growth hormone-releasing hexapeptides, a ghrelin-receptor agonist that prompts a pulse of the body's own growth hormone along with a marked increase in appetite. A distinct and much-studied second property is growth-hormone-independent cytoprotection: acting through the scavenger receptor CD36, it has reduced oxidative damage and necrosis in animal models of myocardial infarction and other tissue injury. It is used as a research peptide and has been employed diagnostically in tests of growth-hormone secretion.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
Agonist prompting GH synthesis and release
Indirect rise via increased GH
Reinforces the nighttime GH pulse
Strongly stimulates hunger
Agonist driving pituitary GH release
Binds ectodomain to trigger prosurvival, antioxidant signaling
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.
easiest to source: GHRP-6 is currently listed by more trusted vendors (6), so it's the simpler one to get hold of. for effects and safety, read each full entry; this is educational, not medical advice.